Microbial factors in disease emergence illustrated by streptococcal toxic shock syndrome.
Krause
R
R
Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA. harrisos@fic16.fic.nih.gov
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001427:Bacterial Toxins / Q000276:immunology; D005075:Biological Evolution; D006801:Humans; D007113:Immunity, Innate; D007116:Immunization, Passive; D012541:Scarlet Fever / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology; D012772:Shock, Septic / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D018461:Soft Tissue Infections / Q000382:microbiology; D013290:Streptococcal Infections / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology*; D013297:Streptococcus pyogenes / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D014612:Vaccines / Q000276:immunology
D000900:Anti-Bacterial Agents; D001427:Bacterial Toxins; D014612:Vaccines